Scientific publications

Clinical guideline for management of patients with low risk differentiated thyroid carcinoma

Díez JJ(1), Oleaga A(2), Álvarez-Escolá C(3), Martín T(4), Galofré JC [SP](5); en representación del Grupo de Trabajo de Cáncer de Tiroides de la Sociedad Española de Endocrinología y Nutrición.
(1) Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Universidad de Alcalá de Henares, Madrid, España.
(2) Servicio de Endocrinología y Nutrición, Hospital Universitario Basurto, Bilbao, España.
(3) Servicio de Endocrinología y Nutrición, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, España.
(4) Servicio de Endocrinología, Hospital Universitario Virgen Macarena, Sevilla, España.
(5) Departamento de Endocrinología, Clínica Universidad de Navarra, Pamplona, España. 

Magazine: Endocrinología y Nutrición

Date: Apr 6, 2015

Thyroid Disease Area Endocrinology and Nutrition [SP]

ABSTRACT

Incidence of thyroid cancer is increasing in Spain and worldwide. Overall thyroid cancer survival is very high, and stratification systems to reliably identify patients Aworse prognosis have been developed.

However, marked differences exist between the different specialists in clinical management of low-risk patients with thyroid carcinoma. Almost half of all papillary thyroid carcinomas are microcarcinomas, and 90% are tumors < 2cm that have a particularly good prognosis. However, they are usually treated more aggressively than needed, despite the lack of adequate scientific support.

Surgery remains the gold standard treatment for these tumors. However, lobectomy may be adequate in most patients, without the need for total thyroidectomy. Similarly, prophylactic lymph node dissection of the central compartment is not required in most cases.

This more conservative approach prevents postoperative complications such as hypoparathyroidism or recurrent laryngeal nerve injury. Postoperative radioiodine remnant ablation and strict suppression of serum thyrotropin, although effective for the more aggressive forms of thyroid cancer, have not been shown to be beneficial for the treatment of low risk patients, and may impair their quality of life.

This guideline provides recommendations from the task force on thyroid cancer of the Spanish Society of Endocrinology and Nutrition for adequate management of patients with low-risk thyroid cancer.

CITATION  Endocrinol Nutr. 2015 Apr 6. pii: S1575-0922(15)00076-5. doi: 10.1016/j.endonu.2015.02.006

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra